Javascript must be enabled to use this form.

View Profile	Home Browse Faculty Facility Research Consortia Training Grants Courses Search Support About rSp Help and FAQ's Contact Us	GCC Home
Faculty Profile Last Modified Time: 10:15:34 AM Mon, 6 Apr 2020   Contact Information Charles Cleeland Associated Profiles  Clinical Research Director, McCullough Professor of Cancer Research, Symptom Research, UT MD Anderson Cancer Center     ccleeland@mdanderson.org     713-745-3470    Web Link    Pain, Neoplasms, Equipment and Supplies, Fatigue, Pain Management, Quality of Life, Therapeutics, Analgesics    Associated Profiles Research and Expertise Affiliations Appointments  Research and Expertise Research Interests   Dr. Cleeland and his colleagues in the Department of Symptom Research have developed assessment tools (the Brief Pain Inventory, Brief Fatigue Inventory, and M. D. Anderson Symptom Inventory) to measure symptom severity and how symptoms interfere with patient functioning. These tools are widely used internationally in clinical trials evaluating symptom-management treatments. As Director of the WHO Collaborating Center for Supportive Cancer Care, Dr. Cleeland worked with colleagues in Asia, Europe, and the United States to verify that our symptom-assessment scales work well in various linguistic and cultural contexts to allow development of multinational clinical trials and cross-cultural epidemiological symptom studies. Through ongoing international collaborations, he works to further the stateside training of clinicians and researchers from other countries, provide resources to educate abroad, encourage treatment of cancer-related pain and other symptoms for those without access to expensive curative treatments, and promote palliative care programs in countries with limited health care resources. Dr. Cleeland's long-term research goals are to prevent the development of symptoms and to develop enhanced treatments for the symptoms of cancer and cancer treatment, which may lead to improvement in patient function, stress level, satisfaction with and willingness to endure therapy, and quality of life during and after treatment. He is especially interested in the role of inflammation as a physiological mechanism potentially responsible for symptom-cluster generation and in biological response modifiers as agents for symptom reduction and prevention. Based on animal models of inflammation-induced sickness behavior, he hypothesizes that inflammation and its downstream toxic effects represent a significant biological basis for subjectively reported clusters of symptoms, cognitive impairment, and neuropathies. Control or prevention of cancer-related cytokine dysregulation may provide a basis for experimental therapies that could significantly reduce or even preclude the emergence of cancer-related symptoms.  Publications/Creative Works Click here to search for this faculty member's publications on PubMed.  Affiliations  Research Consortia Gulf Coast Cluster for Translational Pain Research  Appointments Title Department / School Institution Clinical Research Director Symptom Research MD Anderson Cancer Center

powering - The Partnership
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.